Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald S Go

Showing results (111-120 of 402) with videos related to

Pageof 41
Sort By:
Cancer|May 17, 2016
Influence of the treatment facility volume on the survival of patients with non-Hodgkin lymphomaRonald S Go, Mohammed Al-Hamadani, Nilay D Shah, et al.
American Journal of Hematology|June 23, 2015
Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011Mohammed Al-Hamadani, Thomas M Habermann, James R Cerhan, et al.
European Journal of Haematology|January 19, 2005
Human cyclic thrombocytopenia and Anaplasma spp. infectionRonald S Go, Steven D Lovrich, Steven M Callister, et al.
British Journal of Haematology|September 3, 2019
Concomitant Erdheim-Chester disease and chronic myelomonocytic leukaemia: genomic insights into a common clonal originGaurav Goyal, Yuanhang Liu, Aishwarya Ravindran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2018
Reply to E.L. Pollom et al, N. Ohri et al, A. Fiorentino et al, D.R. Wahl et al, N. Kim et al, J. Boda-Heggemann et al, S. Rana et al, N. Sanuki et al, J.R. Olsen et al, G.L. Smith et al, and A. Shinde et alDevalkumar J Rajyaguru, Andrew J Borgert, Thorvardur R Halfdanarson, et al.
Mayo Clinic Proceedings|January 24, 2026
Pleuropulmonary Involvement in Erdheim-Chester Disease: Analysis of 24 Biopsy-Proven CasesSteven Tessier, Aldo A Acosta-Medina, Brandon T Larsen, et al.
Leukemia & Lymphoma|June 11, 2016
Estimating the annual volume of hematologic cancer cases per hematologist-oncologist in the United States: are we treating rare cancers too rarely?Aishwarya Ravindran, Wilson I Gonsalves, Shahrukh K Hashmi, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 10, 2017
Treatment Patterns and Outcomes in Early-stage Hodgkin Lymphoma in the Elderly: A National Cancer Database AnalysisGaurav Goyal, Edward B Maldonado, Tiffany J Fan, et al.
Journal of the Neurological Sciences|November 13, 2025
Intra-arterial melphalan for treatment of neurologic histiocytic neoplasmsFederico Montini, Waleed Brinjikji, Ronald S Go, et al.
American Journal of Hematology|June 18, 2011
Proportions of bone marrow lymphocyte subsets at diagnosis may predict survival in patients with newly diagnosed diffuse large B-cell lymphoma independently of the international prognostic indexLuke D Zurbriggen, Jacob D Gundrum, Seema M Policepatil, et al.
Pageof 41

Showing results (111-120 of 402) with videos related to

Sort By:
Pageof 41
Cancer|May 17, 2016
Influence of the treatment facility volume on the survival of patients with non-Hodgkin lymphomaRonald S Go, Mohammed Al-Hamadani, Nilay D Shah, et al.
American Journal of Hematology|June 23, 2015
Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: A longitudinal analysis of the National Cancer Data Base from 1998 to 2011Mohammed Al-Hamadani, Thomas M Habermann, James R Cerhan, et al.
European Journal of Haematology|January 19, 2005
Human cyclic thrombocytopenia and Anaplasma spp. infectionRonald S Go, Steven D Lovrich, Steven M Callister, et al.
British Journal of Haematology|September 3, 2019
Concomitant Erdheim-Chester disease and chronic myelomonocytic leukaemia: genomic insights into a common clonal originGaurav Goyal, Yuanhang Liu, Aishwarya Ravindran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2018
Reply to E.L. Pollom et al, N. Ohri et al, A. Fiorentino et al, D.R. Wahl et al, N. Kim et al, J. Boda-Heggemann et al, S. Rana et al, N. Sanuki et al, J.R. Olsen et al, G.L. Smith et al, and A. Shinde et alDevalkumar J Rajyaguru, Andrew J Borgert, Thorvardur R Halfdanarson, et al.
Mayo Clinic Proceedings|January 24, 2026
Pleuropulmonary Involvement in Erdheim-Chester Disease: Analysis of 24 Biopsy-Proven CasesSteven Tessier, Aldo A Acosta-Medina, Brandon T Larsen, et al.
Leukemia & Lymphoma|June 11, 2016
Estimating the annual volume of hematologic cancer cases per hematologist-oncologist in the United States: are we treating rare cancers too rarely?Aishwarya Ravindran, Wilson I Gonsalves, Shahrukh K Hashmi, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 10, 2017
Treatment Patterns and Outcomes in Early-stage Hodgkin Lymphoma in the Elderly: A National Cancer Database AnalysisGaurav Goyal, Edward B Maldonado, Tiffany J Fan, et al.
Journal of the Neurological Sciences|November 13, 2025
Intra-arterial melphalan for treatment of neurologic histiocytic neoplasmsFederico Montini, Waleed Brinjikji, Ronald S Go, et al.
American Journal of Hematology|June 18, 2011
Proportions of bone marrow lymphocyte subsets at diagnosis may predict survival in patients with newly diagnosed diffuse large B-cell lymphoma independently of the international prognostic indexLuke D Zurbriggen, Jacob D Gundrum, Seema M Policepatil, et al.
Pageof 41